Huang Y - Search Results

1

Hypoxia-activated glutamine antagonist prodrug combined with combretastatin A4 nanoparticles for tumor-selective metabolic blockade.

Zheng M, Xu H, Huang Y, Sun J, Zhang H, Lv Z, Liu Z, Tang Z, Chen X. Zheng M, et al. Among authors: huang y. J Control Release. 2024 Jan;365:480-490. doi: 10.1016/j.jconrel.2023.11.054. Epub 2023 Dec 2. J Control Release. 2024. PMID: 38040341

2

pH-Triggered charge-reversal polypeptide nanoparticles for cisplatin delivery: preparation and in vitro evaluation.

Huang Y, Tang Z, Zhang X, Yu H, Sun H, Pang X, Chen X. Huang Y, et al. Biomacromolecules. 2013 Jun 10;14(6):2023-32. doi: 10.1021/bm400358z. Epub 2013 May 21. Biomacromolecules. 2013. PMID: 23662624

3

An Fc Binding Peptide-Based Facile and Versatile Build Platform for Multispecific Antibodies.

Xue F, Yao H, Cui L, Huang Y, Shao C, Shen N, Hu J, Tang Z, Chen X. Xue F, et al. Among authors: huang y. Nano Lett. 2023 May 24;23(10):4191-4200. doi: 10.1021/acs.nanolett.3c00071. Epub 2023 May 15. Nano Lett. 2023. PMID: 37186944

4

Preparation and Characterization Evaluation of Poly(L-Glutamic Acid)-g-Methoxy Poly(Ethylene Glycol)/Combretastatin A4/BLZ945 Nanoparticles for Cervical Cancer Therapy.

Guo D, Huang Y, Wang K, Yang C, Ma L, Zhang Y, Yu H, Cui M, Tang Z. Guo D, et al. Among authors: huang y. Int J Nanomedicine. 2023 Nov 22;18:6901-6914. doi: 10.2147/IJN.S441131. eCollection 2023. Int J Nanomedicine. 2023. PMID: 38026524 Free PMC article.

5

The combination of IL-2 nanoparticles and Palbociclib enhances the anti-tumor immune response for colon cancer therapy.

Wang D, Wang X, Zhang Y, Yu L, An J, Wang X, Huang Y, Han X. Wang D, et al. Among authors: huang y. Front Immunol. 2024 Jan 30;15:1309509. doi: 10.3389/fimmu.2024.1309509. eCollection 2024. Front Immunol. 2024. PMID: 38352877 Free PMC article.

6

Therapeutic effects and underlying mechanism of poly (L-glutamic acid)-g-methoxy poly (ethylene glycol)/combretastatin A4/BLZ945 nanoparticles on Renca renal carcinoma.

Chen J, Yin M, Yang C, Wang K, Ma L, Yu H, Huang Y, Liu F, Tang Z. Chen J, et al. Among authors: huang y. Front Bioeng Biotechnol. 2024 Feb 5;12:1336692. doi: 10.3389/fbioe.2024.1336692. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 38375454 Free PMC article.

7

Hypoxia-Responsive Aggregation of Gold Nanoparticles for Near-Infrared-II Photoacoustic Imaging-Guided Enhanced Radiotherapy.

Geng H, Chen K, Cao L, Liu L, Huang Y, Liu J. Geng H, et al. Among authors: huang y. Langmuir. 2023 Mar 21;39(11):4037-4048. doi: 10.1021/acs.langmuir.2c03399. Epub 2023 Mar 12. Langmuir. 2023. PMID: 36907993

8

Bilateral Spondylolysis of Lumbar Vertebra Secondary to Long Spinal Fusion for Idiopathic Scoliosis: A Case Report and Review of Literature.

Huang Y, Dong Y, Liu F, Li Y, Wang H, Zhang J. Huang Y, et al. Orthop Surg. 2024 Oct;16(10):2569-2573. doi: 10.1111/os.14175. Epub 2024 Aug 7. Orthop Surg. 2024. PMID: 39113353 Free PMC article. Review.

9

Design, synthesis, and anti-inflammatory evaluation of a series of novel amino acid-binding 1,5-diarylpyrazole derivatives.

Li MH, Yin LL, Cai MJ, Zhang WY, Huang Y, Wang X, Zhu XZ, Shen JK. Li MH, et al. Among authors: huang y. Acta Pharmacol Sin. 2005 Jul;26(7):865-72. doi: 10.1111/j.1745-7254.2005.00151.x. Acta Pharmacol Sin. 2005. PMID: 15960895

10

Unveiling chemotherapy-induced immune landscape remodeling and metabolic reprogramming in lung adenocarcinoma by scRNA-sequencing.

Huang Y, Wu G, Bi G, Cheng L, Liang J, Li M, Zhang H, Shan G, Hu Z, Chen Z, Lin Z, Jiang W, Wang Q, Xi J, Yin S, Zhan C. Huang Y, et al. Elife. 2024 Dec 27;13:RP95988. doi: 10.7554/eLife.95988. Elife. 2024. PMID: 39729352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81,571 results

Search Page

Filters